A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to further develop a novel virus inactivation process, successfully used for MERS, which has the potential to inactivate the SARS-CoV-2 virus.
How far apart should the trumpet section be from the trombone section at my first band rehearsal during COVID-19?
The research team used existing technologies to treat nine plasma and three whole-blood products.
CSU investigators will run tests for up to 45,000 workers and nursing home residents in the state.
Using a manufacturing platform developed to prevent the transmission of disease during blood transfusions, IDRC staffers are working with the faculty of several departments at CSU to test an internally developed vaccine candidate dubbed SolaVAX.
Over the last two months, a team at CSU tested samples from 462 healthcare workers in Colorado.
Prepared with the necessary certification for laboratory testing performed on humans, the Veterinary Diagnostic Laboratory is ready to help the local community process more coronavirus tests.
Over the last decade, there have been advances in manufacturing and in strategies to rapidly produce a vaccine.